More than 1,000 Susan G. Komen for the Cure breast cancer advocates, grantees, corporate partners and volunteers converged in Fort Worth, Texas, for the 2011 Susan G. Komen Leadership Conference this past weekend. It was two days of learning, sharing and re-committing to the community outreach, research and advocacy that only Komen does in thousands of communities and 50 countries worldwide. A highlight of the weekend was a visit from philanthropist David Rubenstein, who shared his unique insights on charitable giving:
We’re grateful for donors like David, and for our more than 200 corporate partners, hundreds of grantees and of course, our Komen Affiliates who make our work possible in your neighborhood. We heard about how our research is moving the needle on metastatic and aggressive disease; and how our community programs helped screen some 700,000 women last year. Our advocacy is helping to keep breast cancer programs intact for low-income and uninsured women across the country; and our global work is opening doors for women in countries where cancer still brings stigma and shame.
We were so happy to have members of our family in town to share best-in-class knowledge and practices, celebrating our accomplishments in the breast cancer movement and inspire each other to keep moving forward.
We are truly the boldest community united against breast cancer.
Be sure to check out some pictures from the Leadership Conference below and on Flickr.
March 17, 2011 Breast Cancer, Breast Cancer News, Global, Komen Advocacy, Komen Leadership News, Komen News, Mission
We are all devastated by the ongoing crisis in Japan. More than 70 nations have opened their hearts and wallets to assist with food, medicine and dollars. But humanitarian assistance takes many forms, and the global cancer community has a vital role to play to help address a looming cancer crisis caused by the nuclear accidents in Japan.
You can help us in our efforts to avert this potential cancer crisis. As leader of the world’s largest breast cancer organization, I am calling on global cancer leaders to develop a cancer action plan – today — for Japan. I need your support to show that we are all unified for the people of Japan, and for those who may be affected by nuclear accidents today and into the future, wherever they may live.
I know the devastation that these accidents can cause. I served on the National Cancer Advisory Board after the Chernobyl accident, horrified to see an aftermath that produced the largest group of cancers ever. It’s been 25 years since Chernobyl, but exposure to fallout may be responsible for thyroid cancers that are still occurring in people who lived there.
We must act now and we are. Susan G. Komen for the Cure will convene a panel of global experts to immediately begin addressing the future cancer risks generated from this incident and draft a plan of action.
Here’s where you can help. We are asking all of you — our vast network of global friends and supporters — to sign a petition calling for the release of all information regarding the accident and the potential effects of migrating radiation. As Japan works to contain the current crisis and provide for the immediate needs of its citizens, we urge the government to partner with the global cancer community to help protect the long term public health of people in Japan and around the world.
Please show your support by signing our petition at the link below.SIGN OUR PETITION
The New York Times recently featured a story raising concerns about the “unrealistic optimism” that many cancer patients have who sign up for early Phase I or II clinical trials. Some doctors and ethicists worried that too many volunteers have their hopes too high that the drug or treatment being tested will conquer their cancer. But George Sledge, M.D., a member of our Scientific Advisory Board, isn’t all that concerned about the volunteers’ high hopes. In fact, as he writes in the current edition of the ASCO Connection, he’s proud of them.
Check out Dr. Sledge’s article here.
A special thanks to our emcee Donald Trump and all who helped raise $800,000 for Komen’s research and community programs during the first Perfect Pink Party at the Mar-a-Lago in Palm Beach last Friday night. The event marked the promise that our founder and CEO Nancy G. Brinker made to her sister, Susan G. Komen, to end breast cancer forever. It was great to celebrate with terrific guests in a sea of pink!
Trump – who is a Susan G. Komen for the Cure New York Ambassador — donated an additional $25,000 during the evening. Among our special guests were: Stage 3 triple negative breast cancer survivor, FOX News correspondent and Komen for the Cure Global Ambassador Jennifer Griffin, who introduced four Komen research grantees: Amelie Ramirez of the University of Texas at San Antonio, Dr. Powel Brown, professor and chairman of Clinical Cancer Prevention at MD Anderson (Ramirez and Brown are both members of our Scientific Advisory Board), Ana Maria Gonzalez-Angulo of MD Anderson Cancer Center in Houston, and Dr. Thomas Buckholz chair of the radiation oncology department and executive director of the Morgan Welch Inflammatory Breast Cancer center at MD Anderson.
As the 2011 Perfect Pink Party winds up, the Pink Passions Auction is in full swing. The auction features many one-of-a-kind designer creations and exclusive experiences from the worlds’ greatest luxury brands. To see the items and participate, visit www.charitybuzz.com/PerfectPink through March 23, 2011.
Be sure to check out more photos from the gala on the Palm Beach Post website.
Guest post from Patty Spears, Cheryl Jernigan, Mary Elliott and Sandy Finestone, breast cancer research advocate members to the Komen Scholars.
The Komen Scholars was established in 2010 to provide the Susan G. Komen for the Cure Scientific Advisory Board with advice and expertise in scientific peer review of research applications. The Komen Scholars are a diverse group of breast cancer experts and leaders in research coming together as one council, for one cause: to put an end to breast cancer! The Scholars met for the first time last week to discuss the current Komen for the Cure grant review process and current research projects.
The meeting started with a welcome lunch where the Scholars connected with each other prior to the discussion. Komen president, Liz Thompson, and the rest of the staff introduced the organization and presented an overview of the grant review process. In a room full of renowned scientists and research advocates, all comments were welcomed and listened to!
Each session encouraged conversation resulting in suggestions for future processes. Comments and concerns were provided, and our collective knowledge resulted in many suggestions that will enhance the Komen grant review process and outcomes.
We also heard presentations from each of the researchers leading several Komen Promise Grants – some of the most innovative and translational research funded by Komen. Based on particular areas of expertise, many of the Scholars offered new ideas or possible enhancements to the research projects already underway.
There is still much work that needs to be done and our ability to fund leading breast cancer research is becoming more crucial to achieving an end to breast cancer.
The scientific leadership of the Komen Scholars is very impressive and we are proud to be valued partners with Komen in this fight. Research advocates and scientists working together as Komen Scholars can ensure the research we fund will change the breast cancer landscape and lead to better prevention, diagnosis, treatments and, ultimately, the cures.